Study on Data Acquisition and Image Characteristics of Brain Multifrequency EIT in Healthy People and Patients With Brain Diseases

Sponsor
Jieshi Ma (Other)
Overall Status
Completed
CT.gov ID
NCT05796349
Collaborator
(none)
24
1
7
3.4

Study Details

Study Description

Brief Summary

The goal of this observational study is to compare the differences in the features of cerebral multifrequency EIT(cMFEIT) images between healthy subjects and patients with brain diseases and to explore the possibility of applying multifrequency EIT to intracranial abnormality detection.16 healthy volunteers and 8 patients with brain diseases were recruited as experimental subjects, and the cerebral EIT data of 9 frequencies in the range of 21 kHz - 100 kHz of all subjects were acquired with an EH-300 MFEIT system.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: multifrequency EIT-based for detecting intracranial abnormalities

Detailed Description

For subjects who received clinical trials, 16 electrodes were placed equidistantly in their head, and brain EIT data were measured at 9 frequencies in the range of 21 kHz to 100 kHz by applying a current RMS of 176 microamps. The healthy group included 16 individuals (male, age 40.25±11.18). No history of brain disease and no abnormalities were seen on plain CT scans of their brains. Cerebral EIT data collection from healthy volunteers was performed in a dedicated laboratory with temperature controlled at 24±1 °C and 52%±1% humidity in 2022. The subjects were lying in a horizontal position. The patient group included 8 patients with brain diseases (7 males, age 59±10.46). Obvious lesions were visible on the patients' CT or MRI images, including 6 patients with intracranial hemorrhage, 1 patient with cerebral ischemia, and 1 patient with cerebral edema. Data from patients with brain diseases were collected at the neurosurgical intensive care unit at the Army Medical Center of PLA in 2022. The cerebral EIT data of the patients were collected in the same position as the healthy individuals. The MFEIT image sequence is obtained according to a certain imaging algorithm, and the ROI area ratio (AR_ROI) on the left and right sides of the image and the average value of the reconstructed ROI resistivity change (MVRRC_ROI) are extracted. Based on the extracted indicators, the geometric asymmetry index (GAI) and intensity asymmetry index (IAI) was further proposed to characterize the symmetry of MFEIT images, and the differences between the two groups of subjects on MFEIT images were statistically compared and analyzed.

Study Design

Study Type:
Observational
Actual Enrollment :
24 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Study on Data Acquisition and Image Characteristics of Brain Multifrequency EIT in Healthy People and Patients With Brain Diseases
Actual Study Start Date :
Jun 1, 2022
Actual Primary Completion Date :
Dec 30, 2022
Actual Study Completion Date :
Dec 30, 2022

Arms and Interventions

Arm Intervention/Treatment
healthy group

The healthy group included 16 individuals (male, age 40.25±11.18). No history of brain disease and no abnormalities were seen on plain CT scans of their brains.

Diagnostic Test: multifrequency EIT-based for detecting intracranial abnormalities
For subjects who received clinical trials, 16 electrodes were placed equidistantly in their head, and brain EIT data were measured at 9 frequencies in the range of 21 kHz to 100 kHz by applying a current RMS of 176 microamps.MFEIT image sequences were obtained according to certain imaging algorithms.

patient group

The patient group included 8 patients with brain diseases (7 males, age 59±10.46). Obvious lesions were visible on the patients' CT or MRI images, including 6 patients with intracranial hemorrhage, 1 patient with cerebral ischemia, and 1 patient with cerebral edema

Diagnostic Test: multifrequency EIT-based for detecting intracranial abnormalities
For subjects who received clinical trials, 16 electrodes were placed equidistantly in their head, and brain EIT data were measured at 9 frequencies in the range of 21 kHz to 100 kHz by applying a current RMS of 176 microamps.MFEIT image sequences were obtained according to certain imaging algorithms.

Outcome Measures

Primary Outcome Measures

  1. Whether there is a significant difference in the characteristic indicators (such as symmetry indicators) of multifrequency EIT images between healthy individuals and patients with brain diseases. [Up to 12 days after the patient's onset]

    When there are significant differences in these indicators (such as symmetry indicators) (p<0.05), there is no need for further data collection

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Health Group: No history of brain disease and no abnormalities were seen on plain CT scans of their brains.

  2. Patient Group: Patients with cerebral hemorrhage, cerebral ischemia, and cerebral edema, less than 12 days after onset.

Exclusion Criteria:
  1. Health Group:
  • Neurological diseases such as epilepsy, brain tumors, and cerebral vascular malformations;

  • Neurological symptoms such as headache and dizziness;

  • Abnormal signals detected on CT.

  1. Patient Group:
  • With other brain diseases without cerebral hemorrhage, cerebral ischemia, or brain edema;

  • With open craniocerebral injury;

  • With severe agitation.

Contacts and Locations

Locations

Site City State Country Postal Code
1 PLA Army Characteristic Medical Center Chongqing Chongqing China 400042

Sponsors and Collaborators

  • Jieshi Ma

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jieshi Ma, Deputy Director of MedicaEngineering Department, Army Medical Center of PLA
ClinicalTrials.gov Identifier:
NCT05796349
Other Study ID Numbers:
  • AMCPLA
First Posted:
Apr 3, 2023
Last Update Posted:
Apr 3, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jieshi Ma, Deputy Director of MedicaEngineering Department, Army Medical Center of PLA
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 3, 2023